Arteris Inc’s recent filing unveils that its President and CEO JANAC K CHARLES unloaded Company’s shares for reported $0.32 million on Jan 15 ’26. In the deal valued at $17.84 per share,17,884 shares were sold. As a result of this transaction, JANAC K CHARLES now holds 9,399,071 shares worth roughly $157.34 million.
Then, Bayview Legacy, LLC sold 17,884 shares, generating $318,974 in total proceeds. Upon selling the shares at $17.84, the 10% Owner now owns 9,399,071 shares.
Before that, JANAC K CHARLES sold 2,116 shares. Arteris Inc shares valued at $37,644 were divested by the President and CEO at a price of $17.79 per share. As a result of the transaction, JANAC K CHARLES now holds 9,416,955 shares, worth roughly $157.64 million.
TD Cowen reiterated its Arteris Inc [AIP] rating to a Buy in a research note published on August 06, 2025; the price target was $15. A number of analysts have revised their coverage, including TD Cowen’s analysts, who remained covering the stock and in early September has reiterated a ‘”an Outperform”‘ rating for it. Cowen also remained covering AIP and reiterated its “an Outperform” recommendation on March 04, 2022. Rosenblatt started covering the stock on November 22, 2021. It rated AIP as “a Buy”.
Price Performance Review of AIP
On Tuesday, Arteris Inc [NASDAQ:AIP] saw its stock fall -4.72% to $16.74. Over the last five days, the stock has lost -3.63%. Arteris Inc shares have risen nearly 46.20% since the year began. Nevertheless, the stocks have risen 8.00% over the past one year.
How much short interest is there in Arteris Inc?
A steep rise in short interest was recorded in Arteris Inc stocks on 2025-12-31, dropping by -0.34 million shares to a total of 1.53 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 1.87 million shares. There was a decline of -22.04%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 22, 2021 when Northland Capital began covering the stock and recommended ‘”an Outperform”‘ rating along with a $27 price target.
